Quantcast
Channel: GenomeWeb - AstraZeneca
Browsing all 58 articles
Browse latest View live

Researchers Seek Best Approach to Identify Lung Cancer Patients With...

View Article


Lynparza Delays Progression in Metastatic Pancreatic Cancer Patients With...

View Article


TAPUR Study Investigators Report First Positive Findings, Pursuing...

View Article

AstraZeneca, Merck's Lynparza, Myriad Genetics' BRCA Test Approved in Japan

View Article

FDA Approves Foundation Medicine CDx Test for Lynparza

View Article


Guardant Health Hopes Lung Cancer Stakeholder Alignment Will Help Advance...

View Article

Myriad Genetics Seeking Additional FDA Approval for BRACAnalysis CDx

View Article

UK Biobank Whole-Genome Sequencing Project Obtains £200M from Pharma,...

View Article


Getting Them Sequenced

View Article


Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer...

View Article

PetaGene Sees AstraZeneca Deal as Validation of Genomic Data Compression...

View Article

FDA Approves AstraZeneca's Lynparza, Myriad Genetics' CDx for BRCA-Positive...

View Article

Veracyte, Acerta Pharma Launch Biopharmaceutical Collaboration

View Article


Myriad Genetics Files for FDA Approval of BRACAnalysis CDx for Lynparza in...

View Article

FNIH Team Selects Cancer Biomarkers in Phase I of Liquid Biopsy Reference...

View Article


Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master...

View Article

Myriad Files sPMA With FDA for Test to ID Best Responders to Lynparza,...

View Article


Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer...

View Article

Novacyt, AstraZeneca, GSK, University of Cambridge Partner to Increase...

View Article

FDA Approves Lynparza/Avastin With Myriad Genetics CDx for Platinum-Sensitive...

View Article
Browsing all 58 articles
Browse latest View live